1,086 material Form 8-K filings that 883 companies we cover made with the SEC in July 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Centene reported second quarter 2025 results in a press release furnished as Exhibit 99.1 to this 8-K. The company posted a GAAP diluted loss of $(0.51) per share, compared with diluted earnings of $2.16 per share a year earlier, driven primarily by a reduction in its net 2025 Marketplace risk adjustment revenue transfer estimate. Revenue grew while profit fell, and the company said it will provide 2025 earnings expectations on its July 25, 2025 conference call.
GAAP diluted loss per share was $(0.51) versus $2.16 in Q2 2024; adjusted diluted loss per share was $(0.16) versus $2.42 a year earlier.
Total revenues were $48.7 billion, up from $39.8 billion; premium and service revenues rose 18% to $42.5 billion.
Health benefits ratio was 93.0% versus 87.6% in Q2 2024, mainly due to the lower Marketplace risk adjustment revenue estimate and higher Marketplace and Medicaid medical costs.
Cash flow provided by operations was $1.8 billion, primarily driven by improved pharmacy rebate remittance timing.
Ovintiv reported second quarter 2025 net earnings of $307 million, or $1.18 per diluted share, down from $340 million, or $1.27 per diluted share, a year earlier, while total revenues rose to $2,318 million from $2,288 million. The company raised full-year production guidance to 600 to 620 MBOE/d and lowered full-year capital guidance to $2.125 billion to $2.175 billion, and declared a $0.30 quarterly dividend.
Q2 2025 net earnings were $307 million ($1.18 diluted per share), compared with $340 million ($1.27 diluted per share) in Q2 2024.
Total revenues were $2,318 million, up from $2,288 million in Q2 2024.
Full-year 2025 production guidance raised to 600 to 620 MBOE/d; capital guidance lowered to $2.125 billion to $2.175 billion, $50 million lower at the midpoint.
Quarterly dividend of $0.30 per share is payable September 29, 2025, to holders of record as of September 15, 2025.
SLM Corporation, which operates as Sallie Mae, reported second quarter 2025 GAAP diluted earnings of $0.32 per share, down from $1.11 a year earlier. The drop reflected provisions for credit losses of $149 million, up from $17 million, and lower non-interest income, while net interest income rose slightly. For shareholders, the quarter shows a sharp fall in earnings, and the company's full-year 2025 GAAP diluted EPS guidance of $3.00 to $3.10 is the key figure to watch.
Q2 2025 GAAP diluted EPS was $0.32, versus $1.11 in Q2 2024 and $1.40 in Q1 2025
Provisions for credit losses were $149 million in Q2 2025, compared with $17 million in Q2 2024
Total non-interest income was $27 million, down from $142 million a year earlier
Full-year 2025 guidance: GAAP diluted EPS of $3.00 to $3.10 and non-interest expenses of $655 million to $675 million
Edwards Lifesciences reported second-quarter 2025 sales of $1.53 billion, up 11.9% from a year earlier, and adjusted EPS of $0.67. The company raised its full-year 2025 sales growth guidance to 9% to 10% and its adjusted EPS outlook to the high end of $2.40 to $2.50. GAAP net income attributable to Edwards fell to $333.2 million from $366.3 million, partly due to a $47.1 million impairment loss.
Q2 sales $1.53 billion, up 11.9%; TAVR sales $1.1 billion, up 8.9%; TMTT sales $134.5 million, up 61.9%
Full-year 2025 sales guidance raised to 9% to 10%, or $5.9 billion to $6.1 billion; TAVR sales guidance raised to $4.3 billion to $4.5 billion
Adjusted diluted EPS $0.67 in Q2; full-year adjusted EPS now expected at the high end of $2.40 to $2.50
Q2 GAAP diluted EPS $0.56 versus $0.61 a year earlier, including a $47.1 million loss on impairment
Digital Realty reported second-quarter 2025 revenue of $1.49 billion, up 10% from the same quarter a year earlier, and diluted net income of $2.94 per share versus $0.20 a year earlier. The company raised its 2025 Core FFO per share outlook to $7.15 to $7.25 from $7.05 to $7.15 set in April, which matters to shareholders because it reflects higher expected recurring cash earnings per share.
Q2 2025 Core FFO of $1.87 per diluted share, versus $1.65 in Q2 2024 and $1.77 in Q1 2025
Q2 2025 total bookings expected to generate $135 million of annualized GAAP rental revenue at the company's share
Quarter-end backlog of signed-but-not-commenced leases was $826 million of annualized GAAP base rent
Subsequent to quarter end, the company sold a five-megawatt non-core Atlanta data center for $65 million gross proceeds
Mohawk Industries reported second-quarter 2025 net earnings of $147 million, or $2.34 per diluted share, down from $157 million and $2.46 a year earlier, with net sales flat at $2.8 billion. The Board approved a new $500 million share repurchase program on July 24, 2025, and the company expects third-quarter adjusted EPS of $2.56 to $2.66.
Q2 2025 net earnings were $147 million and diluted EPS was $2.34, versus $157 million and $2.46 in Q2 2024
Adjusted EPS was $2.77, versus $3.00 a year earlier; net sales were $2.8 billion, essentially flat as reported
Board approved a new $500 million share repurchase program on July 24, 2025; $0.2 million remains under the 2022 program
Third-quarter adjusted EPS is expected to be $2.56 to $2.66, excluding restructuring or other one-time charges
Healthpeak reported second-quarter 2025 diluted net income of $0.05 per share, down from $0.21 a year earlier, while Nareit FFO was $0.43 per share versus $0.44 and FFO as Adjusted and AFFO rose to $0.46 and $0.44 per share. The company cut its full-year 2025 diluted earnings per share guidance to $0.25 to $0.31 from $0.30 to $0.36 and Nareit FFO guidance to $1.78 to $1.84 from $1.81 to $1.87, while reaffirming its FFO as Adjusted guidance of $1.81 to $1.87 per share.
Q2 2025 diluted net income was $0.05 per share versus $0.21 in Q2 2024.
Q2 2025 Nareit FFO was $0.43 per share versus $0.44; FFO as Adjusted was $0.46 versus $0.45; AFFO was $0.44 versus $0.40.
2025 diluted EPS guidance lowered to $0.25 to $0.31 from $0.30 to $0.36; Nareit FFO guidance lowered to $1.78 to $1.84 from $1.81 to $1.87.
Monthly dividend of $0.10167 per share declared for July, August and September 2025, totaling $0.305 for the third quarter; approximately $2.3 billion of liquidity as of July 24, 2025.
Phillips Edison & Company reported second quarter 2025 results on July 24, 2025, with Core FFO up 10.3% to $88.2 million and total revenues of $177.8 million, while net income attributable to stockholders fell to $12.8 million from $15.3 million. The company raised its full-year 2025 Core FFO per share guidance to $2.55 to $2.60 from $2.52 to $2.59, which matters to shareholders because it signals higher expected earnings for the year.
Q2 2025 net income attributable to stockholders was $12.8 million, or $0.10 per diluted share, compared with $15.3 million, or $0.12, in Q2 2024.
Q2 2025 Core FFO rose 10.3% to $88.2 million, or $0.64 per diluted share, from $80.0 million, or $0.59, a year earlier.
Full-year 2025 Core FFO per share guidance was raised to $2.55 to $2.60 from $2.52 to $2.59.
Management will discuss results on a conference call and webcast on Friday, July 25, 2025, at 12:00 p.m. Eastern Time.
The Ensign Group reported second-quarter 2025 GAAP diluted earnings per share of $1.44, up 18.0% from the prior year quarter, and GAAP net income of $84.4 million, up 18.9%. The company raised its full-year 2025 diluted EPS guidance to $6.34 to $6.46 from $6.22 to $6.38, and its revenue guidance to $4.99 billion to $5.02 billion from $4.89 billion to $4.94 billion, which matters to shareholders because it signals higher expected profit and sales for the year.
Q2 2025 total revenue was $1.23 billion, up 18.5% from the prior year quarter.
GAAP diluted EPS was $1.44 versus $1.22 a year earlier; adjusted diluted EPS was $1.59, up 20.5%.
2025 diluted EPS guidance raised to $6.34 to $6.46; revenue guidance raised to $4.99 billion to $5.02 billion.
Cash on hand was approximately $364.0 million, with $592.6 million of available line-of-credit capacity.
Bancorp reported second-quarter 2025 net income of $59.8 million, or $1.27 per diluted share, up from $1.05 a year earlier, with net income up 11% and share count reduced by buybacks. The company kept its 2025 EPS guidance of $5.25 and announced Project 7, targeting at least a $7 EPS run-rate by the fourth quarter of 2026, though net interest margin fell to 4.44% from 4.97% and consumer fintech loan provisions reached $43.2 million.
Net income of $59.8 million, or $1.27 per diluted share, versus $53.7 million, or $1.05, in Q2 2024
2025 EPS guidance of $5.25 maintained; Project 7 targets at least a $7 EPS run-rate by Q4 2026
Net interest margin fell to 4.44% from 4.97%; provision for consumer fintech loans was $43.2 million
Outstanding shares fell 6% to 46.3 million from 49.3 million after repurchasing 753,898 shares at an average $49.75
VeriSign reported second-quarter 2025 revenue of $410 million, up 5.9% from a year earlier, with net income of $207 million and diluted EPS of $2.21, compared with $199 million and $2.01. The board also authorized about $913 million in additional share repurchases, bringing the total available under the program to $1.5 billion, with no expiration date.
Operating income was $281 million, compared with $266 million in the second quarter of 2024.
Diluted EPS was $2.21, compared with $2.01 a year earlier.
The board approved a new quarterly cash dividend of $0.77 per share, payable August 27, 2025, to holders of record on August 19, 2025.
The total repurchase authorization is $1.5 billion; the company repurchased $163 million of stock in the second quarter.
Comfort Systems USA reported second-quarter 2025 net income of $230.8 million, or $6.53 per diluted share, up from $134.0 million, or $3.74 per share, a year earlier. The company also declared a quarterly dividend of $0.50 per share, up $0.05 from its most recent payout, which gives shareholders a higher cash return.
Q2 2025 revenue was $2.17 billion, compared with $1.81 billion in Q2 2024.
Backlog reached $8.12 billion as of June 30, 2025, up from $5.77 billion a year earlier.
Quarterly dividend of $0.50 per share is payable August 25, 2025, to holders of record on August 14, 2025.
BJ's Restaurants said it retained William J. Atkins, a partner at FLG Partners, as its Interim Principal Financial Officer, effective July 28, 2025, while it searches for a permanent Chief Financial Officer. The company will pay FLG Partners $650 per hour for his services under a consulting agreement, so shareholders will see the interim finance leadership and its hourly cost.
Atkins, age 63, has been a partner at FLG Partners since 2023 and previously served as CFO of Mobileum, Inc. and One Concern.
The interim appointment is effective July 28, 2025, and the company's search for a CFO is ongoing.
The FLG Consulting Agreement took effect July 14, 2025, at $650 per hour, with an indefinite term and termination on 30 days' notice by either party.
The full consulting agreement will be filed as an exhibit to the Form 10-Q for the quarter ended July 1, 2025.
SouthState reported second-quarter 2025 net income of $215.2 million, or $2.11 diluted earnings per share, up from $132.4 million and $1.73 a year earlier, and up from $89.1 million in the first quarter of 2025. The board also raised the quarterly cash dividend by 11%, from $0.54 to $0.60 per share, payable August 15, 2025.
Diluted EPS of $2.11 for Q2 2025, versus $1.73 for Q2 2024; net income of $215.2 million versus $132.4 million a year earlier
Merger, branch consolidation, severance and other expense of $24.4 million in Q2 2025, down from $68.0 million in Q1 2025
Quarterly dividend increased from $0.54 to $0.60 per share; payable August 15, 2025 to shareholders of record as of August 8, 2025
Management conference call set for July 25, 2025 at 9 a.m. ET
FirstCash reported second-quarter 2025 GAAP diluted earnings per share of $1.34, up from $1.08 a year earlier, as net income rose to $59.8 million from $49.1 million, while revenue was roughly flat at $830.6 million. The company raised parts of its 2025 outlook for its U.S. and Latin America pawn segments, and declared a 11% higher quarterly dividend of $0.42 per share.
Q2 2025 GAAP diluted EPS was $1.34 versus $1.08 in Q2 2024, up 24%; net income was $59.8 million versus $49.1 million.
Q2 2025 total revenue was $830.6 million versus $831.0 million a year earlier.
Outlook raised for U.S. pawn fee growth to 10% to 12% (from 9% to 11%) and for Latin America pawn revenue; AFF net revenue decline now expected at 6% to 8% (from 8% to 12%).
Quarterly cash dividend of $0.42 per share, an 11% increase, payable August 29, 2025 to holders of record as of August 15, 2025.
Neogen Corporation appointed Mikhael Nassif as President and Chief Executive Officer, effective August 11, 2025. Nassif most recently served as Global President of Point-of-Care Diagnostics at Siemens Healthineers, and his offer includes a $800,000 base salary and a $4,500,000 target long-term incentive grant.
Mikhael Nassif, age 49, becomes CEO effective August 11, 2025, joining from Siemens Healthineers where he served as Global President of Point-of-Care Diagnostics since September 2022.
Base salary is $800,000, with an annual bonus target of 100% of base salary under the Incentive Compensation Plan.
Sign-on equity grant of $2,000,000 (50% stock options, 50% RSUs) and a one-time cash award of $500,000 payable by September 5, 2025, subject to repayment if employment ends within one year.
Sonic Automotive reported second quarter 2025 revenue of $3.7 billion, up 6% year-over-year, but a net loss of $45.6 million, or $1.34 per diluted share, after a $172.4 million non-cash franchise asset impairment charge. The company also raised its quarterly cash dividend 9% to $0.38 per share, which matters to shareholders because it increases the regular cash payment while GAAP results turned to a loss.
Total revenues were $3.7 billion, up 6%, and gross profit was $602.2 million, up 12%.
Reported net loss was $45.6 million, or $1.34 per share, compared with net income of $41.2 million, or $1.18 per diluted share, a year earlier.
Excluding certain items, adjusted earnings per diluted share were $2.19, up 49%, a non-GAAP measure the company defines.
Quarterly dividend rises to $0.38 per share, payable October 15, 2025, to holders of record on September 15, 2025.
Advance Auto Parts said preliminary unaudited second-quarter 2025 results for the quarter ended July 12, 2025 fall in the upper range of its expectations, with net sales of $1.98 billion to $2.00 billion and flat comparable store sales. The company also announced debt financing transactions to establish a revised structure, including a planned asset-backed revolving loan facility to refinance its $1.0 billion revolving loan facility, which it says will support liquidity and a future return to an investment grade credit rating.
Preliminary Q2 2025 net sales of $1.98 billion to $2.00 billion
Year-over-year comparable store sales change of 0.0% to +0.1%
Adjusted operating income margin of 2.8% to 3.0%, a non-GAAP measure
Planned asset-backed revolving loan facility to refinance the $1.0 billion revolving loan facility; full results due before market open on August 14, 2025
Integer Holdings reported second-quarter 2025 sales of $476 million, up 11% from a year earlier, and GAAP diluted EPS from continuing operations of $1.04, up 18%. The company raised the midpoint of its 2025 adjusted operating income and adjusted EPS outlook. Total debt rose $212 million since the end of 2024 to $1.202 billion, mainly to finance acquisitions and a 2030 convertible note offering, a factor to weigh alongside the higher profit outlook.
Q2 2025 sales were $476 million, up 11%, with organic growth of 11%.
Q2 GAAP diluted EPS from continuing operations was $1.04, up 18%; adjusted EPS was $1.55, up 19%.
2025 outlook: adjusted operating income growth of 12% to 16% and adjusted EPS growth of 18% to 23%.
Total debt was $1.202 billion at June 27, 2025, up $212 million from year-end 2024; leverage ratio of 3.2 times adjusted EBITDA.
Darling Ingredients reported second-quarter 2025 net income of $12.7 million, or $0.08 per diluted share, down from $78.9 million, or $0.49 per share, a year earlier, driven by lower earnings at Diamond Green Diesel (DGD). Total net sales were flat at $1.5 billion, and combined adjusted EBITDA fell to $249.5 million from $273.6 million. The company adjusted its 2025 combined adjusted EBITDA outlook to $1.05-$1.10 billion, citing uncertainty over small refinery exemptions and RIN pricing.
Q2 2025 net income attributable to Darling was $12.7 million ($0.08 per diluted share), versus $78.9 million ($0.49) in Q2 2024.
Total net sales were $1.5 billion in both periods; six-month net loss was $13.5 million, or $(0.09) per diluted share.
Combined adjusted EBITDA was $249.5 million for Q2 2025, compared with $273.6 million a year earlier.
2025 combined adjusted EBITDA outlook adjusted to $1.05-$1.10 billion; the company also refinanced long-term debt and signed a non-binding term sheet to form Nextida, a collagen and gelatin company.
MarineMax reported fiscal third-quarter 2025 revenue down 13.3% to $657.2 million and a net loss of $52.1 million, or $2.42 per share, including a non-cash $69.1 million goodwill impairment. The company also cut its fiscal 2025 adjusted EPS guidance to $0.45 to $0.95 from $1.40 to $2.40, which lowers expected profit for shareholders.
Revenue fell 13.3% to $657.2 million from $757.7 million; gross margin was 30.4% versus 32.0% a year earlier.
Net loss of $52.1 million, or $2.42 per share, versus net income of $31.6 million, or $1.37 per diluted share, a year earlier.
Adjusted diluted EPS was $0.49 versus $1.51; adjusted EBITDA was $35.5 million versus $70.4 million.
Fiscal 2025 adjusted EPS guidance cut to $0.45 to $0.95 from $1.40 to $2.40; adjusted EBITDA guidance cut to $105 to $120 million from $140 to $170 million.
World Acceptance reported first-quarter fiscal 2026 results with total revenue up 2.3% to $132.5 million, while net income fell to $1.3 million from $9.9 million and diluted EPS fell to $0.25 from $1.79. The company also replaced its prior credit facility with a three-year, $640.0 million senior secured revolver, approved a $100.0 million share repurchase program, and called its 7.000% notes due 2026 for redemption.
Net income was $1.3 million versus $9.9 million a year earlier; diluted EPS was $0.25 versus $1.79.
Provision for credit losses rose to $50.5 million from $45.4 million; net charge-offs were 19.4% of average net loans, up from 16.4%.
New $640.0 million revolving credit agreement with Bank of Montreal dated July 22, 2025, replacing the prior $730.0 million facility.
Board approved a repurchase program of up to $100.0 million, and the 7.000% notes (aggregate principal $168.3 million) will be redeemed on August 29, 2025 at 101.750%.
HNI Corporation reported second-quarter 2025 results on July 24, 2025, with net sales up 7.0% to $667.1 million and GAAP diluted EPS of $1.02, compared with $0.75 a year earlier. The company said its 2025 earnings outlook increases modestly, with double-digit percentage EPS growth now expected, which matters to shareholders because it points to higher profits for the full year.
Net sales rose 7.0% to $667.1 million; net income attributable to HNI was $48.2 million versus $36.0 million a year earlier.
GAAP diluted EPS was $1.02 versus $0.75; non-GAAP diluted EPS was $1.11 versus $0.79.
The company expects double-digit percentage EPS growth for 2025 and says its outlook for 2025 earnings increases modestly.
Third-quarter 2025 non-GAAP diluted EPS is expected to increase slightly from 2024 levels; the company repurchased nearly $40 million of stock in the quarter.
LKQ reported second-quarter 2025 revenue of $3.6 billion, down 1.9% from a year earlier, and adjusted diluted EPS of $0.87, down 11.2%. The company lowered its full-year 2025 outlook, citing weak repairable claims in North America, tariff uncertainty, and economic softness in Europe, which lowers the expected adjusted diluted EPS range to $3.00 to $3.30.
Q2 2025 revenue was $3.6 billion, down 1.9%; parts and services organic revenue fell 3.4%.
Q2 GAAP diluted EPS rose 7.1% to $0.75, while adjusted diluted EPS fell 11.2% to $0.87.
Full-year adjusted diluted EPS outlook cut to $3.00 to $3.30 from $3.40 to $3.70; operating cash flow outlook cut to $0.875 to $1.075 billion from $1.075 to $1.275 billion.
Board declared a quarterly dividend of $0.30 per share, payable August 28, 2025; $1.6 billion remains under the repurchase program.
West Pharmaceutical Services reported second-quarter 2025 net sales of $766.5 million, up 9.2%, with diluted EPS of $1.82 versus $1.51 a year earlier. The company raised its full-year 2025 net sales guidance to $3.040 billion to $3.060 billion and its adjusted-diluted EPS guidance to $6.65 to $6.85, both up from prior ranges.
Q2 2025 net sales of $766.5 million rose 9.2%; organic net sales grew 6.8%.
Adjusted-diluted EPS was $1.84, compared with $1.52 in the second quarter of 2024.
Full-year 2025 adjusted-diluted EPS guidance rose to $6.65 to $6.85 from $6.15 to $6.35.
Board approved a fourth-quarter 2025 dividend of $0.22 per share, payable November 19, 2025 to holders of record as of November 12, 2025.
Visteon reported second-quarter 2025 sales of $969 million, down from $1,014 million a year earlier, and net income attributable to the company of $65 million, down from $71 million. The company raised its full-year 2025 sales, adjusted EBITDA and adjusted free cash flow guidance and initiated a quarterly dividend of $0.275 per share, which shareholders may weigh against the lower quarterly sales and profit.
Q2 2025 sales were $969 million versus $1,014 million in Q2 2024; diluted EPS was $2.36 versus $2.54.
Full-year 2025 guidance: sales $3.70 billion to $3.85 billion (up from $3.65 billion to $3.85 billion); adjusted EBITDA $475 million to $505 million (up from $450 million to $480 million).
Board approved a quarterly dividend of $0.275 per share, payable September 5, 2025, to holders of record on August 18, 2025.
Company paused share repurchases in Q2 due to tariff uncertainty and plans to resume capital returns opportunistically.
Iridium reported second-quarter 2025 total revenue of $216.9 million, up 8%, and operational EBITDA of $121.3 million, up 6%. Net income fell to $22.0 million from $32.3 million a year earlier, which included a one-time $19.8 million gain, and the company cut its full-year service revenue growth forecast to 3%-5% from 5%-7%. Shareholders also get a quarterly dividend increase to $0.15 per share from $0.14.
Q2 2025 net income was $22.0 million, or $0.20 per diluted share, versus $0.27 a year earlier; the prior-year period included a one-time $19.8 million gain.
Full-year 2025 service revenue growth guidance was lowered to 3%-5% from 5%-7%; full-year OEBITDA guidance of $490 million to $500 million was maintained.
Board declared a $0.15 per share dividend, payable September 30, 2025, to holders of record as of September 15, 2025.
The company repurchased about 2.6 million shares for $65.0 million in the quarter; $295.3 million remained under the program as of June 30, 2025.
American Airlines reported second-quarter 2025 revenue of $14.4 billion, a record for the company, up 0.4% from a year earlier. GAAP net income fell 16.4% to $599 million, or $0.91 per diluted share, and the company guided to an adjusted loss of $0.10 to $0.60 per diluted share for the third quarter. For shareholders, higher revenue did not offset lower profit, and the company expects a third-quarter loss.
Q2 2025 revenue of $14.4 billion, up 0.4% year over year; GAAP net income of $599 million, down from $717 million, or $0.91 per diluted share versus $1.01
Q2 operating margin of 7.9% as reported, versus 9.7% a year earlier
Third-quarter 2025 adjusted loss per diluted share guided to between ($0.10) and ($0.60); full-year adjusted EPS guided to between ($0.20) and $0.80, midpoint $0.30
Ended the quarter with $12 billion of total available liquidity and $29 billion of net debt
Wabtec reported second-quarter 2025 GAAP diluted earnings per share of $1.96, up 19.5%, and sales of $2.71 billion, up 2.3%. The company raised its 2025 adjusted EPS guidance to $8.55 to $9.15, which it attributed to first-half performance, acquisitions and cost management.
GAAP diluted EPS was $1.96 and adjusted diluted EPS was $2.27, up 15.8% from a year earlier.
Full-year 2025 adjusted EPS guidance rose to $8.55 to $9.15, up $0.20 at the mid-point.
Revenue guidance was raised by $200 million at the mid-point to a range of $10.925 billion to $11.225 billion, largely reflecting the Evident Inspection Technologies Division acquisition completed July 1, 2025.
Operating cash flow was $209 million versus $235 million a year earlier, partly due to delayed second-quarter locomotive deliveries.
A. O. Smith reported second-quarter 2025 net sales of $1,011.3 million, down 1% from a year earlier, and net earnings of $152.2 million, down 3%. Diluted EPS rose 1% to $1.07, and the company raised its full-year sales outlook and the midpoint of its diluted EPS outlook, which now stands at $3.70 to $3.90. The company also said it is assessing strategic options for its China business, which matters to shareholders because the outcome and timing are not yet set.
Q2 2025 net sales were $1,011.3 million, down 1% from $1,024.3 million; net earnings were $152.2 million, down 3% from $156.2 million.
Diluted EPS was $1.07 versus $1.06 a year earlier, a 1% increase.
2025 outlook: net sales of $3,850 million to $3,930 million (growth of 1% to 3%) and diluted EPS of $3.70 to $3.90.
The company is assessing its China business, including possible strategic partnerships, with no timetable set; guidance excludes any outcome from that review.
L3Harris reported second-quarter 2025 revenue of $5.4 billion, up 2% (6% organic), and diluted EPS of $2.44, up 27% from a year earlier. The company raised its 2025 non-GAAP diluted EPS guidance to $10.40-$10.60 from $10.30-$10.50 and its 2025 revenue guidance to about $21.75 billion from $21.4-$21.7 billion, which points to higher expected profit and sales for shareholders.
Revenue of $5.4 billion, up 2%; GAAP diluted EPS of $2.44, up 27%; non-GAAP diluted EPS of $2.78, up 16%
2025 non-GAAP diluted EPS guidance raised to $10.40-$10.60 from $10.30-$10.50; the tax rate increase is a headwind of about $0.30 at the midpoint
2025 revenue guidance raised to about $21.75 billion from $21.4-$21.7 billion
Cash from operations fell 15% to $640 million, driven by working capital timing and cash used for a longstanding legal settlement
Ryder reported second-quarter 2025 results for the period ended June 30, 2025. GAAP EPS from continuing operations rose 11% to $3.15, and comparable EPS rose 11% to $3.32, while total revenue was flat at $3.2 billion. The company increased its 2025 free cash flow forecast by $500 million to $900 million to $1 billion and kept a 2025 comparable EPS range of $12.85 to $13.30.
GAAP EPS from continuing operations was $3.15 versus $2.83 a year earlier; comparable EPS was $3.32 versus $3.00.
Total revenue was $3,189 million versus $3,182 million; operating revenue (non-GAAP) rose 2% to $2,610 million.
2025 free cash flow (non-GAAP) forecast is $900 million to $1 billion, up $500 million; 2025 comparable EPS forecast is $12.85 to $13.30.
Fleet Management Solutions earnings before taxes fell 6% to $126 million, offset by a 16% rise in Supply Chain Solutions to $99 million.
Atlantic Union Bankshares reported second-quarter 2025 net income available to common shareholders of $16.8 million, or $0.12 per share, and adjusted diluted operating earnings of $0.95 per share. The results include its April 1, 2025 acquisition of Sandy Spring Bancorp, which brought $78.9 million in merger-related costs and $100.9 million in Day 1 credit loss provision expense.
GAAP net income available to common shareholders was $16.8 million, or $0.12 basic and diluted per share, for Q2 2025.
Adjusted diluted operating earnings were $0.95 per share, excluding items such as $78.9 million in merger-related costs and $100.9 million in CECL Day 1 provision expense.
Net interest income rose $137.2 million to $321.4 million from the first quarter, mainly due to the Sandy Spring acquisition.
Nonperforming assets were 0.60% of total loans held for investment at June 30, 2025, up 22 basis points from the prior quarter.
Bread Financial reported second-quarter 2025 net income of $139 million, or $2.94 per diluted share, up from $2.66 a year earlier, while revenue fell 1% to $929 million. The company improved its full-year 2025 net loss rate guidance to 7.8% to 7.9%, but said lower billed late fees will modestly pressure its full-year revenue expectation.
Q2 2025 net income $139 million and diluted EPS $2.94, versus $133 million and $2.66 in Q2 2024
Revenue $929 million, down 1% from $939 million; average credit card and other loans $17.7 billion, down 1%
2025 net loss rate guidance of 7.8% to 7.9%; full-year revenue expectation modestly pressured by lower billed late fees
Quarterly cash dividend of $0.21 per share, payable September 12, 2025 to holders of record August 8, 2025
Labcorp reported second-quarter 2025 revenue of $3.53 billion, up from $3.22 billion a year earlier, and diluted EPS of $2.84 versus $2.43. The company raised its full-year 2025 guidance for enterprise revenue, adjusted EPS and free cash flow, which is a positive signal for shareholders on both sales and earnings.
Q2 revenue $3.53 billion vs $3.22 billion; diluted EPS $2.84 vs $2.43; adjusted EPS $4.35 vs $3.94
Adjusted EPS guidance range narrowed to $16.05 to $16.50 from $15.70 to $16.40; midpoint raised by $0.23
Free cash flow guidance of $1.13 billion to $1.28 billion, midpoint raised by $25 million
Quarterly dividend of $0.72 per share declared July 10, 2025, payable September 11, 2025; $200 million of stock repurchased in the quarter
CNX Resources reported second quarter 2025 results in Exhibit 99.1 of this 8-K. Net income was $432.5 million, or $2.53 per diluted share, compared with a net loss of $197.7 million, or $1.34 per share, in the first quarter, mainly because of a $421.1 million gain on commodity derivative instruments. The company kept its 2025 adjusted EBITDAX and total free cash flow guidance unchanged, narrowed its production guidance, and raised its free cash flow per share guidance to about $4.07 from about $3.97.
Q2 2025 net income was $432.5 million (diluted EPS $2.53) versus a Q1 2025 net loss of $197.7 million (EPS of $(1.34))
Natural gas, NGL and oil revenue fell to $485.0 million from $551.1 million in Q1 2025; adjusted net income was $100 million versus $116 million in Q1
2025 production guidance narrowed to 615 to 620 Bcfe from 605 to 620 Bcfe; adjusted EBITDAX guidance stayed at $1,225 to $1,275 million
Free cash flow per share guidance rose to about $4.07 from about $3.97, based on 141,418,560 shares outstanding as of 7/15/2025
Dover reported second-quarter 2025 results on July 24, 2025, with revenue of $2.0 billion, up 5% (1% organic), and GAAP diluted EPS from continuing operations of $2.03, up 14%. The company raised its full-year 2025 adjusted EPS guidance to $9.35-$9.55 from $9.20-$9.40, while GAAP EPS guidance remains $8.00-$8.20.
Q2 2025 adjusted diluted EPS from continuing operations was $2.44, up 16% from $2.10 a year earlier.
Six-month GAAP EPS from continuing operations was $3.76, down 38%, mainly due to the 2024 gain on the De-Sta-Co disposition.
Full-year 2025 adjusted EPS guidance was raised to $9.35-$9.55 from $9.20-$9.40, based on revenue growth of 4% to 6%.
Management said it completed two acquisitions in the Pumps & Process Solutions segment during the quarter.
Textron reported second quarter 2025 revenue of $3.7 billion, up 5.4% or $189 million from a year earlier, and adjusted EPS of $1.55 versus $1.54. GAAP EPS was flat at $1.35, and GAAP income from continuing operations fell to $245 million from $260 million. The company reiterated its full-year 2025 EPS outlook and raised its manufacturing cash flow outlook to $900 million to $1.0 billion, up $100 million.
Q2 revenue $3.7 billion, up 5.4% or $189 million; Bell revenue up $222 million to $1.0 billion
Q2 GAAP EPS $1.35, flat; adjusted EPS $1.55 versus $1.54 a year earlier
2025 manufacturing cash flow before pension contributions now expected at $900 million to $1.0 billion, up $100 million; GAAP EPS outlook of $5.19 to $5.39 reiterated
Textron returned $214 million to shareholders through share repurchases in Q2 and $429 million year to date
Brunswick reported second quarter 2025 net sales of $1,447.0 million, roughly flat year over year, while GAAP diluted EPS fell to $0.90 from $1.55 and as adjusted diluted EPS fell to $1.16 from $1.80. The company kept its full-year as adjusted diluted EPS guidance midpoint at approximately $3.25 and raised its free cash flow expectation to more than $400 million, but provided Q3 adjusted EPS of $0.75 to $0.90 on revenue of $1.1 to $1.3 billion, which is below the prior-year level.
Q2 2025 net sales $1,447.0 million, up 0.2% from $1,443.9 million; GAAP operating earnings $103.3 million, down 34.7%
Full-year 2025 guidance: net sales of approximately $5.2 billion, as adjusted diluted EPS of approximately $3.25, free cash flow above $400 million
Q3 2025 guidance: revenue of $1.1 to $1.3 billion and as adjusted diluted EPS of $0.75 to $0.90
Free cash flow of $288 million in Q2 2025, a second-quarter record; $43 million of share repurchases through the second quarter
TransUnion reported second quarter 2025 revenue of $1,140 million, up 10% from a year earlier, and net income attributable to TransUnion of $110 million, compared with $85 million. The company raised its full-year 2025 revenue growth expectation to 6 to 7 percent, which signals higher expected sales growth for shareholders.
Diluted EPS was $0.56 versus $0.44 in Q2 2024; Adjusted Diluted EPS was $1.08 versus $0.99.
Adjusted EBITDA was $407 million, up 8%, with a margin of 35.7% versus 36.2% a year earlier.
2025 revenue growth guidance is now 6 to 7 percent on both reported and organic constant currency bases.
The company repurchased $47 million of shares through mid-July and reported 2.8x leverage at quarter-end.
Honeywell reported second-quarter 2025 sales of $10.4 billion, up 8% from a year earlier, with adjusted earnings per share of $2.75, up 10%. The company raised its full-year organic growth and adjusted EPS guidance, but lowered its segment margin guidance, and said it will evaluate strategic alternatives for two businesses.
Q2 sales of $10.4 billion rose 8% reported and 5% organic; GAAP EPS was $2.45, up 4%
Full-year adjusted EPS guidance is now $10.45 to $10.65, up from $10.20 to $10.50
Full-year sales guidance is $40.8 billion to $41.3 billion, up from $39.6 billion to $40.5 billion; segment margin guidance is 23.0% to 23.2%, down from 23.2% to 23.5%
Announced strategic alternatives review for Productivity Solutions and Services and Warehouse and Workflow Solutions; Advanced Materials spin targeted for Q4 2025
Dow reported a second-quarter 2025 GAAP net loss of $801 million, or $1.18 per share, compared with net income of $458 million a year earlier. Operating EBIT was a loss of $21 million, down $840 million year over year, and operating EPS was a loss of $0.42 versus earnings of $0.68 in the year-ago period. The CEO said Dow is adjusting its dividend to maintain a balanced capital allocation framework, but the filing does not state the new dividend amount.
Net sales were $10.1 billion, down 7% year over year, with local price down 7% and volume down 1%.
GAAP loss per share was $1.18, including significant items of $0.76 per share, mainly restructuring severance and asset-related charges.
Cash provided by operating activities from continuing operations was negative $470 million, compared with positive $832 million in the year-ago quarter.
Dow paid $496 million in dividends in the quarter and said it is adjusting its dividend, without giving a new amount.
Allegion reported second-quarter 2025 net revenues of $1,022.0 million, up 5.8%, and diluted earnings of $1.85 per share, up from $1.77 a year earlier. The company raised its full-year 2025 reported revenue growth outlook to 6.5% to 7.5% and its full-year EPS outlook to $7.25 to $7.40, or $8.00 to $8.15 on an adjusted basis.
Q2 2025 diluted EPS was $1.85 versus $1.77; adjusted EPS was $2.04, up 4.1%.
Q2 2025 revenue rose 5.8% to $1,022.0 million, with organic growth of 3.2%.
Q2 2025 operating margin was 21.5% versus 21.6%; adjusted operating margin was flat at 23.7%.
Full-year 2025 tariff costs are estimated at about $40 million, with the company expecting to offset them at the operating profit and EPS level, primarily through pricing actions.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.